Eung Suck Lee

Title: Eung Suck Lee: Innovator in Cholangiocarcinoma Treatment

Introduction

Eung Suck Lee is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the treatment of cholangiocarcinoma, a type of cancer that affects the bile ducts. His innovative work has led to the development of a pharmaceutical composition that targets this aggressive cancer.

Latest Patents

Eung Suck Lee holds a patent for a pharmaceutical composition aimed at treating cholangiocarcinoma. The patent details a method for inhibiting the growth or invasion of cholangiocarcinoma using an L1CAM activity inhibitor or expression suppressor. This invention is based on the discovery that L1CAM is overexpressed in cholangiocarcinoma and plays a crucial role in the cancer's growth and metastasis. The patent outlines how antibodies that inhibit L1CAM activity or siRNAs that suppress its expression can significantly reduce the growth and invasion of cholangiocarcinoma cells.

Career Highlights

Eung Suck Lee is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His work has been instrumental in advancing the understanding of cholangiocarcinoma and developing effective treatment methods. His research has the potential to improve outcomes for patients suffering from this challenging disease.

Collaborations

Eung Suck Lee has collaborated with notable colleagues, including Hyo Jeong Hong and Jung-Whoi Lee. These partnerships have contributed to the success of his research and the development of innovative treatment strategies.

Conclusion

Eung Suck Lee's contributions to the field of biotechnology, particularly in the treatment of cholangiocarcinoma, highlight his role as an influential inventor. His patented methods offer hope for improved treatment options for patients facing this difficult diagnosis.